全文获取类型
收费全文 | 45856篇 |
免费 | 2236篇 |
国内免费 | 192篇 |
专业分类
耳鼻咽喉 | 512篇 |
儿科学 | 1005篇 |
妇产科学 | 1057篇 |
基础医学 | 5991篇 |
口腔科学 | 2602篇 |
临床医学 | 3333篇 |
内科学 | 11469篇 |
皮肤病学 | 1086篇 |
神经病学 | 3592篇 |
特种医学 | 900篇 |
外国民族医学 | 1篇 |
外科学 | 5883篇 |
综合类 | 215篇 |
一般理论 | 17篇 |
预防医学 | 4692篇 |
眼科学 | 835篇 |
药学 | 2899篇 |
中国医学 | 238篇 |
肿瘤学 | 1957篇 |
出版年
2023年 | 366篇 |
2022年 | 512篇 |
2021年 | 1301篇 |
2020年 | 749篇 |
2019年 | 1252篇 |
2018年 | 1845篇 |
2017年 | 1110篇 |
2016年 | 1086篇 |
2015年 | 1389篇 |
2014年 | 1725篇 |
2013年 | 2186篇 |
2012年 | 3648篇 |
2011年 | 3986篇 |
2010年 | 1945篇 |
2009年 | 1565篇 |
2008年 | 3038篇 |
2007年 | 3204篇 |
2006年 | 2921篇 |
2005年 | 2750篇 |
2004年 | 2406篇 |
2003年 | 2197篇 |
2002年 | 2090篇 |
2001年 | 577篇 |
2000年 | 623篇 |
1999年 | 509篇 |
1998年 | 263篇 |
1997年 | 209篇 |
1996年 | 152篇 |
1995年 | 126篇 |
1994年 | 98篇 |
1993年 | 117篇 |
1992年 | 276篇 |
1991年 | 218篇 |
1990年 | 195篇 |
1989年 | 158篇 |
1988年 | 128篇 |
1987年 | 128篇 |
1986年 | 123篇 |
1985年 | 107篇 |
1984年 | 85篇 |
1983年 | 84篇 |
1982年 | 56篇 |
1981年 | 62篇 |
1980年 | 40篇 |
1979年 | 55篇 |
1975年 | 49篇 |
1974年 | 68篇 |
1971年 | 48篇 |
1970年 | 47篇 |
1968年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
4.
5.
6.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
7.
8.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
9.
10.